The Chan Zuckerberg Biohub is both an institute and an academic network devoted to accelerating research via cutting edge technologies and open science. Its focus on single-cell analysis and infectious disease has placed it front and center in the pandemic.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
24,99 € / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
212,91 € per year
only 17,74 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout

Change history
17 September 2020
A Correction to this paper has been published: https://doi.org/10.1038/s41587-020-0702-1
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
DeFrancesco, L. The making of the Biohub. Nat Biotechnol 38, 1116–1120 (2020). https://doi.org/10.1038/s41587-020-0685-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-020-0685-y